Patent ID: 7994216
Filing Date: 2011-08-09
Classification: A61K,A61P

Abstract:
1. A method of reducing symptomatology associated with benign prostate hyperplasia (BPH) in a human patient, comprising: administering a catechin preparation; wherein administration of the catechin preparation is specific to a patient that is diagnosed with high-grade prostate intraepithelial neoplasia (HG-PIN) and coexistent benign prostate hyperplasia (BPH), and wherein administration is performed under a protocol that is effective to reduce the symptomatology associated with BPH and to reduce progression of HG-PIN to prostate cancer; and wherein the catechin preparation comprises at least 50 wt % epigallocatechin gallate (EGCG), at least 3 wt % epicatechin gallate (ECG), at least 3 wt % epicatechin (EC), and at least 3 wt % epigallocatechin (EGC).